Correlation Between Lixte Biotechnology and Allarity Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lixte Biotechnology and Allarity Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lixte Biotechnology and Allarity Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lixte Biotechnology Holdings and Allarity Therapeutics, you can compare the effects of market volatilities on Lixte Biotechnology and Allarity Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lixte Biotechnology with a short position of Allarity Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lixte Biotechnology and Allarity Therapeutics.
Diversification Opportunities for Lixte Biotechnology and Allarity Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Lixte and Allarity is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotechnology Holdings and Allarity Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allarity Therapeutics and Lixte Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lixte Biotechnology Holdings are associated (or correlated) with Allarity Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allarity Therapeutics has no effect on the direction of Lixte Biotechnology i.e., Lixte Biotechnology and Allarity Therapeutics go up and down completely randomly.
Pair Corralation between Lixte Biotechnology and Allarity Therapeutics
Given the investment horizon of 90 days Lixte Biotechnology Holdings is expected to generate 1.15 times more return on investment than Allarity Therapeutics. However, Lixte Biotechnology is 1.15 times more volatile than Allarity Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Allarity Therapeutics is currently generating about -0.26 per unit of risk. If you would invest 765.00 in Lixte Biotechnology Holdings on August 24, 2024 and sell it today you would lose (602.00) from holding Lixte Biotechnology Holdings or give up 78.69% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lixte Biotechnology Holdings vs. Allarity Therapeutics
Performance |
| Timeline |
| Lixte Biotechnology |
| Allarity Therapeutics |
Lixte Biotechnology and Allarity Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lixte Biotechnology and Allarity Therapeutics
The main advantage of trading using opposite Lixte Biotechnology and Allarity Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lixte Biotechnology position performs unexpectedly, Allarity Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will offset losses from the drop in Allarity Therapeutics' long position.| Lixte Biotechnology vs. Allarity Therapeutics | Lixte Biotechnology vs. Neurobo Pharmaceuticals | Lixte Biotechnology vs. Virax Biolabs Group | Lixte Biotechnology vs. Quoin Pharmaceuticals Ltd |
| Allarity Therapeutics vs. Immix Biopharma | Allarity Therapeutics vs. Cns Pharmaceuticals | Allarity Therapeutics vs. Sonnet Biotherapeutics Holdings | Allarity Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |